天眼查显示，近日，广东省横琴医维盛世技术服务有限公司成立，法定代表人为李琦，注册资本500万 人民币，江西一脉阳光集团股份有限公司、江西睿境科技有限公司持股。 企业名称广东省横琴医维盛世技术服务有限公司法定代表人李琦注册资本500万国标行业制造业>金属 制品、机械和设备修理业>其他机械和设备修理业地址珠海市横琴新区兴盛一路128号3713办公企业类 型有限责任公司(外商投资企业与内资合资)营业期限2025-12-23至无固定期限登记机关横琴粤澳深度合 作区商事服务局 来源：市场资讯 序号股东名称持股比例1江西一脉阳光集团股份有限公司51%2李琦20%3刘芳照15%4周玫10%5江西睿境 科技有限公司4% 经营范围含通用设备修理；专用设备修理；第二类医疗设备租赁；第一类医疗设备租赁；第一类医疗器 械销售；第二类医疗器械销售；健康咨询服务（不含诊疗服务）；电子、机械设备维护（不含特种设 备）；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广。（除依法须经批准的项目 外，凭营业执照依法自主开展经营活动）许可项目：第三类医疗设备租赁；第三类医疗器械经营。（依 法须经批准的项目，经相关部门批准后方可开展经营活 ...

平安健康医疗科技有限公司是一家通过移动平台和线下资源从事提供医疗及健康服务的公司。该公司通 过两个分部开展其业务。医疗服务分部主要从事在线咨询、转诊及预约挂号、住院安排、疾病诊疗及相 关药品、医疗器械销售。健康服务分部提供多种整合医疗健康机构服务的标准化健康服务包，以满足用 户健康相关需要，覆盖体检、养老、齿科、抗衰、泛健康等多品类及服务形态。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，12月22日南向资金增持235.45万股平安好医生（01833.HK）。近5个交易日中，获南向 资金减持的有2天，累计净减持2919.89万股。近20个交易日中，获南向资金减持的有6天，累计净减持 2764.77万股。截至目前，南向资金持有平安好医生（01833.HK）4.62亿股，占公司已发行普通股的 21.37%。 ...

Core Viewpoint - Recent southbound fund reductions in Ping An Good Doctor (01833.HK) indicate a trend of decreasing investor confidence, with significant net sell-offs over the past weeks [1] Group 1: Southbound Fund Activity - On October 27, southbound funds reduced their holdings by 1.1299 million shares, marking a decrease of 0.25% [2] - Over the last five trading days, there have been three days of reductions, totaling a net decrease of 3.8938 million shares [1][2] - In the past 20 trading days, there were ten days of reductions, with a cumulative net decrease of 6.2143 million shares [1] Group 2: Current Holdings - As of now, southbound funds hold 449 million shares of Ping An Good Doctor, which represents 20.74% of the company's total issued ordinary shares [1] Group 3: Company Overview - Ping An Good Doctor operates through mobile platforms and offline resources to provide medical and health services [2] - The company has two main business segments: the medical services segment, which includes online consultations, referrals, appointment scheduling, hospitalization arrangements, disease diagnosis, and sales of related pharmaceuticals and medical devices; and the health services segment, which offers standardized health service packages to meet various health-related needs [2]

Group 1 - The core point of the news is that southbound funds have increased their holdings in Ping An Good Doctor (01833.HK) by 23,300 shares on October 16, 2025, marking a net increase of 5,995,600 shares over the last five trading days [1][2] - Over the past 20 trading days, southbound funds have reduced their holdings in Ping An Good Doctor for 13 days, resulting in a total net reduction of 15,453,300 shares [1][2] - As of now, southbound funds hold 448 million shares of Ping An Good Doctor, accounting for 20.72% of the company's total issued ordinary shares [1][2] Group 2 - The company, Ping An Health Medical Technology Co., Ltd., operates in the healthcare sector, providing medical and health services through mobile platforms and offline resources [2] - The business is divided into two segments: the medical services segment focuses on online consultations, referrals, appointment scheduling, hospitalization arrangements, disease diagnosis, and related sales of pharmaceuticals and medical devices [2] - The health services segment offers standardized health service packages that integrate various healthcare institution services to meet users' health-related needs, covering areas such as physical examinations, elderly care, dental services, anti-aging, and general health [2]

Group 1 - A new company, Tianjin Yimai Yingrun Medical Imaging Diagnosis Co., Ltd., has been established with a registered capital of 20 million RMB [1] - The legal representative of the company is Ma Zhi Hua, and it is located in the Tianjin Beichen Economic and Technological Development Zone [1] - The company is primarily involved in medical services, medical equipment leasing, and health management services [1] Group 2 - Shareholding structure includes Guangdong Hengqin Yimai Sunshine Medical Management Co., Ltd. (40%), Jiangxi Yimai Sunshine Group Co., Ltd. (30%), Zhao Li (20%), and Jiangxi Quandong Technology Co., Ltd. (10%) [1] - The company operates in the pharmaceutical manufacturing industry, specifically in the chemical drug preparation manufacturing sector [1] - The business scope includes various medical equipment leasing and sales, as well as technology services and consulting [1]

Summary of Key Points Core Viewpoint - Guoke Hengtai (Beijing) Medical Technology Co., Ltd. plans to provide a total guarantee amount of 1.855 billion yuan to its subsidiaries within the next twelve months, with a significant portion allocated to subsidiaries with an asset-liability ratio exceeding 70% [1]. Group 1: Guarantee Overview - The total guarantee amount planned is 1.855 billion yuan, with 1.415 billion yuan designated for subsidiaries with an asset-liability ratio above 70% and 440 million yuan for those below 70% [1]. - The guarantees will be controlled based on the actual effective amounts, and subsidiaries can adjust their guarantee limits within the total amount [1]. - Guarantees exceeding 1.225 billion yuan will require board approval, while those below this threshold can be approved by the general manager's office [1]. Group 2: Risk Management - For guarantees exceeding the company's shareholding ratio, the other shareholders of the guaranteed subsidiaries must provide sufficient and realizable counter-guarantees valued at no less than 1.3 times the amount exceeding the company's shareholding [1]. - If effective counter-guarantees cannot be provided, the company may charge corresponding guarantee fees to mitigate compensation risks [1]. - The guarantee fee rate is set at 1.00% per year for amounts corresponding to the company's shareholding and 2.50% per year for amounts exceeding the shareholding [1]. Group 3: Subsidiary Information - The subsidiaries involved in the guarantee include Guoke Hengxiang (Tianjin) Medical Technology Co., Ltd., Guoke Hengkai (Shanghai) Medical Technology Co., Ltd., and others, with varying asset-liability ratios and ownership structures [4][6]. - The most recent financial data indicates that the asset-liability ratio for the subsidiaries is approximately 75.15% as of March 31, 2025 [4].